**Trader consensus on no new coronavirus pandemic in 2026 reflects persistently low SARS-CoV-2 circulation and stable epidemiological indicators through mid-to-late 2026.** Official WHO surveillance shows global test positivity rates near 1-2% in recent periods, with reported cases and deaths declining to historic lows compared to prior years, supported by widespread population immunity from vaccination and prior infection. No novel variants under monitoring have demonstrated increased virulence or pandemic potential, and current transmission aligns with endemic rather than pandemic patterns. This evidence underpins the 94.4% implied probability for “No.” Realistic challenges include emergence of a highly immune-evasive strain capable of driving widespread severe disease or a new zoonotic coronavirus spillover meeting international health emergency thresholds before year-end.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoNew Coronavirus Pandemic in 2026?
$25,405 Wol.
$25,405 Wol.
$25,405 Wol.
$25,405 Wol.
The resolution source will be official announcements from the World Health Organization.
Rynek otwarty: Jan 6, 2026, 2:40 PM ET
Rozstrzygający
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Rozstrzygający
0x65070BE91...**Trader consensus on no new coronavirus pandemic in 2026 reflects persistently low SARS-CoV-2 circulation and stable epidemiological indicators through mid-to-late 2026.** Official WHO surveillance shows global test positivity rates near 1-2% in recent periods, with reported cases and deaths declining to historic lows compared to prior years, supported by widespread population immunity from vaccination and prior infection. No novel variants under monitoring have demonstrated increased virulence or pandemic potential, and current transmission aligns with endemic rather than pandemic patterns. This evidence underpins the 94.4% implied probability for “No.” Realistic challenges include emergence of a highly immune-evasive strain capable of driving widespread severe disease or a new zoonotic coronavirus spillover meeting international health emergency thresholds before year-end.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano



Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania